Cargando…

OR12-2 Inhibition of Basal and ACTH-stimulated Cortisol Secretion in Humans Using an Oral Nonpeptide ACTH Antagonist (CRN04894)

CRN04894 is a potent orally bioavailable MC2R (adrenal cortex specific ACTH receptor) antagonist (Kb=0.34 nM) that is >1000-fold selective for MC2R over other melanocortin receptor subtypes. In rats receiving continuous administration of ACTH via subcutaneously implanted osmotic pumps, oral admin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Betz, Stephen, Ferrara-Cook, Christine, Hernandez-Illas, Martha, Luo, Rosa, Madan, Ajay, Miller, Stephanie, Struthers, Scott, Trainer, Peter, Wang, Yang, Krasner, Alan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700278/ http://dx.doi.org/10.1210/jendso/bvac150.172

Ejemplares similares

Effects of CRN04894, a Nonpeptide Orally Bioavailable ACTH Antagonist, on Corticosterone in Rodent Models of ACTH Excess
por: Fowler, Melissa A, et al.
Publicado: (2021)

SAT-364 Nonpeptide Orally-Bioavailable ACTH Antagonists: Suppression of ACTH-Induced Corticosterone Secretion and Adrenal Hypertrophy in Rats
por: Kusnetzow, Ana, et al.
Publicado: (2019)

OR19-03 Effects of Nonpeptide Orally Bioavailable ACTH Antagonists on Adrenal Gland Size and Function in Rats
por: Markison, Stacy, et al.
Publicado: (2020)

MON-176 Discovery and Identification of Late Stage Selective Nonpeptide ACTH Antagonists for the Treatment of Cushing’s Disease, Ectopic ACTH Secreting Tumors, and Congenital Adrenal Hyperplasia
por: Kusnetzow, Ana Karin, et al.
Publicado: (2020)

PSUN304 CRN04777 an Oral, Nonpeptide SST5-selective Somatostatin Agonist Dose Dependently Suppresses Basal and Stimulated Insulin Secretion
por: Ferrara-Cook, Christine, et al.
Publicado: (2022)

SAT626 The Use Of Salivary Cortisol Measurement By Mass Spectrometry To Identify Low Serum Cortisol Values In Healthy Volunteers Receiving CRN04894, A Melanocortin 2 Receptor (MC2R) Antagonist
por: Ayala, Alejandro, et al.
Publicado: (2023)

PSAT055 ACTH-Dependent or ACTH-Independent: The Importance of a Reliable ACTH Assay in Solving a Case of Cushing Syndrome
por: Duro, Teodor, et al.
Publicado: (2022)

SUN-187 A Case of Adrenal Mass with Elevated ACTH and Cortisol in a Woman with No Cushingoid Features
por: Rajiyah, Tara, et al.
Publicado: (2020)

RF09 | PSAT88 Pro-opiomelanocortin (POMC), ACTH and Cortisol Responses to Pediatric Cardiac Surgery
por: Téblick, Arno, et al.
Publicado: (2022)

MON-185 ACTH-Derived Peptide Antagonists as an Alternative Treatment Strategy for Congenital Adrenal Hyperplasia
por: Schubert, Tina, et al.
Publicado: (2020)

OR23-05 Human Absorption, Metabolism, Excretion, and Absolute Oral Bioavailability of (14)C-CRN00808, an Orally Bioavailable, Nonpeptide, Selective, Somatostatin Receptor 2 (sST2) Biased Agonist for the Treatment of Acromegaly
por: Madan, Ajay, et al.
Publicado: (2020)

SAT-380 Screening for Central Adrenal Insufficiency in Children with Prader-Willi Syndrome (PWS) with Single Collection Of ACTH and Cortisol Levels
por: Angulo, Moris, et al.
Publicado: (2019)

Severe Cushing Syndrome Due to Ectopic ACTH Secretion by Pheochromocytoma
por: Giorgi, Rafael Buck, et al.
Publicado: (2021)

PSAT054 Isolated ACTH Deficiency in a Patient on Epoprostenol
por: Riordan, Marianne, et al.
Publicado: (2022)

MON-184 Disrupted ACTH-Cortisol Temporal Coupling in Healthy Men After an Overnight Fast, and the Modulatory Role of Orally Ingested Macronutrients
por: Iranmanesh, Ali, et al.
Publicado: (2020)

SUN-168 Case Series of ACTH-Secreting Pheochromocytoma: Diagnosis and Management
por: Tran, Anh, et al.
Publicado: (2020)

Presentation of ACTH Independent Cushing’s as Severe Insulin Resistance During Pregnancy
por: Faisal, Sobia, et al.
Publicado: (2021)

OR25-06 Morning ACTH Levels as a Reliable Biomarker for Excluding Autonomous Cortisol Secretion in Incidetally Discovered Adrenal Adenomas. A Prospective Cohort
por: Olmos, Roberto Ignacio, et al.
Publicado: (2020)

MON-361 Isolated ACTH Deficiency after Treatment with Immune-Checkpoint Inhibitors
por: O'Hare, James, et al.
Publicado: (2019)

SUN-393 ACTH-secreting Pheochromocytoma - A Rare Cause of Cushing’s Syndrome
por: Pujals Kury, Jean, et al.
Publicado: (2019)

SUN-385 A Rare Case of Ectopic ACTH Secretion by Pancreatic Adenocarcinoma
por: Angela, Le, et al.
Publicado: (2019)

SAT-204 ACTH-Producing Pheochromocytoma, a Challenging Disease to Diagnose and Manage
por: Ferrari, Aldo De, et al.
Publicado: (2020)

MON-178 Cyclical Cushing’s Syndrome in 12 Patients with Ectopic ACTH Secretion
por: Zenno, Anna, et al.
Publicado: (2020)

ACTH-Dependent Cushing’s Syndrome in an Elderly Woman with Pituitary, Adrenal, and Intrathoracic Lesions
por: Japp, Emily A, et al.
Publicado: (2021)

ODP047 Intramuscular ACTH stimulation test in a patient with liver disease
por: Khurram, Daniyeh, et al.
Publicado: (2022)

SUN-387 ACTH-Independent Cushing Syndrome from Pregnancy-Induced Micronodular Hyperplasia
por: Affinati, Alison, et al.
Publicado: (2019)

A Re-Examination of the oCRH Stimulation Test for the Diagnosis of Ectopic ACTH Secretion
por: Newman, Andrew Joseph, et al.
Publicado: (2021)

Immunohistochemically ACTH positivity in an adrenal adenoma that mimicks pheochromocytoma in terms of clinical and radiological findings
por: Haydardedeoglu, Filiz E, et al.
Publicado: (2023)

ACTH Antagonists
por: Clark, Adrian John, et al.
Publicado: (2016)

SAT-213 Parotid Carcinoma Ex Pleomorphic Adenoma Can Produce Ectopic ACTH Too
por: Adly, Hussein, et al.
Publicado: (2020)

SUN-198 Metastatic Progression of Adrenocortical Carcinoma: Phenotypic Transformation to ACTH-Independent Cushing’s Syndrome
por: Ocampo, Javier, et al.
Publicado: (2020)

Unravelling the Genetic Basis of ACTH-Mediated Aldosterone Hypersecretion in Hypertensive Patients Without Primary Aldosteronism
por: Mourtzi, Niki, et al.
Publicado: (2021)

FRI223 Ectopic ACTH Syndrome
por: Sudhakar, Shwetha Mallesara, et al.
Publicado: (2023)

PSAT025 Functional Adrenocortical Oncocytic Neoplasm: A Rare Cause of ACTH Independent Cushing's Syndrome
por: Chang, Alan, et al.
Publicado: (2022)

LBODP011 Pembrolizumab Induced Hypophysitis And Resultant Isolated ACTH Deficiency Presenting As Secondary Adrenal Insufficiency.
por: Arora, Gunjan, et al.
Publicado: (2022)

From Bioinactive ACTH to ACTH Antagonist: The Clinical Perspective
por: Ghaddhab, Chiraz, et al.
Publicado: (2017)

Ectopic ACTH-Producing Pheochromocytoma as a Rare Cause for Rapid Progressing Cushing Syndrome: A Case Report
por: Salazar, Daniela, et al.
Publicado: (2021)

PSAT044 Management of Severe Cushing's Syndrome in a Patient with Cyclical Ectopic ACTH Production Treated with Osilodrostat.
por: Obeid, Hiba, et al.
Publicado: (2022)

SAT-429 Final Results from the First in Man Phase 1 Clinical Trial of CRN00808, an Orally Bioavailable sst2-Selective, Nonpeptide Somatostatin Biased Agonist, for the Treatment of Acromegaly: Safety, Pharmacokinetics, Pharmacodynamics, and Midazolam Drug Interaction in Healthy Volunteers
por: Madan, Ajay, et al.
Publicado: (2019)

MON-348 Isolated ACTH Deficiency after Administrating Immune Checkpoint Inhibitors: Report of Three Cases and Review of Literature
por: Edo, Naoki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_foqil0v0m4uu78re64dgem68u9